ECV (TPEx:6689) announced its revenue for February 2023.
4.9 (518) · € 34.99 · En Stock
Kenvue Declares Quarterly Cash Dividend
ECV (TPEx:6689) announced its revenue for September 2023.
2023 nine-month revenue: €98.8 million, up +3% - FY 2023 guidance adjusted
EDGAR Filing Documents for 0001193125-22-147020
September 2023 LSEG/Ipsos Primary Consumer Sentiment Index
CPCA expects China Sept NEV retail sales to be record 750,000 units - CnEVPost
Travelers Companies Inc EVP & Pres., Bond & Spec. Ins. Jeffrey Klenk Sells 17,149 Shares
ESMO 2023: LITESPARK-005 Belzutifan Versus Everolimus in Participants with Previously Treated Advanced Clear Cell Renal Cell Carcinoma: Randomized Open-Label Phase 3
ECV (TPEx:6689) announced its revenue for May 2023.
CES Unveiled Reveals Tech & Buying Trends - Residential Systems
ESMO 2023: LITESPARK-005 Belzutifan Versus Everolimus in Participants with Previously Treated Advanced Clear Cell Renal Cell Carcinoma: Randomized Open-Label Phase 3
